7 authorised products containing Infliximab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Flixabi 100 mg powder for concentrate for solution for infusion EU/1/16/1106/001 |
Infliximab | Samsung Bioepis NL B.V. | — |
| Remicade 100 mg Powder for concentrate for solution for infusion EU/1/99/116/001-5 |
Infliximab | Janssen-Cilag International NV | — |
| Remsima 100 mg powder for concentrate for solution for infusion EU/1/13/853/001 |
Infliximab | Celltrion Healthcare Hungary Kft. | — |
| Remsima 120 mg solution for injection in pre-filled pen EU/1/13/853/012-014 |
Infliximab | Celltrion Healthcare Hungary Kft. | — |
| Remsima 120 mg solution for injection in pre-filled syringe EU/1/13/853/006-011 |
Infliximab | Celltrion Healthcare Hungary Kft. | — |
| Remsima 40 mg/mL concentrate for solution for infusion EU/1/13/853/018-027 |
Infliximab | Celltrion Healthcare Hungary Kft. | — |
| Zessly 100 mg powder for concentrate for solution for infusion EU/1/18/1280/001-005 |
Infliximab | Sandoz GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.